• Revenue and profit growth of over 20% year-on-year
• Successful expansion into new international markets
• Continued investment in R&D and product innovation

Pro Medicus Ltd, a leading provider of healthcare imaging solutions, has reported strong financial results for the first half of the 2025 fiscal year. The company achieved revenue and profit growth of over 20% compared to the same period in the previous year, driven by successful expansion into new international markets and continued investment in research and development. The company's flagship Visage 7 platform has seen increasing adoption globally, with new contract wins in North America, Europe, and Asia-Pacific. Pro Medicus also made significant progress in developing its next-generation imaging solutions, leveraging advanced technologies such as artificial intelligence and cloud computing to enhance the capabilities and efficiency of its products. The company's focus on innovation and global expansion has positioned it well to capitalize on the growing demand for advanced healthcare imaging solutions, and the board remains confident in the company's long-term growth prospects.

For the full 2025 financial year, Pro Medicus expects to deliver revenue and profit growth of 18-22% compared to the previous year.

Pro Medicus is well-positioned for continued growth, with a strong pipeline of new business opportunities and a focus on driving innovation and global expansion. The company remains committed to investing in R&D to enhance its product offerings and maintain its competitive edge in the rapidly evolving healthcare technology market.